Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Number of holders
-
10
-
Total 13F principal, excl. options
-
170,823,077
-
Principal change
-
+3,389,000
-
Total reported value, excl. options
-
$177,255,350
-
Value change
-
-$449,580
-
Number of buys
-
2
-
Number of sells
-
3
-
Price
-
$0.8950
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q3 2025
As of 30 Sep 2025 IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 had 11 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $170,823,077 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included BRAIDWELL LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, DeepCurrents Investment Group LLC, Indaba Capital Management, L.P., D. E. Shaw & Co., Inc., HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, JPMORGAN CHASE & CO, BARCLAYS PLC, Context Capital Management, LLC, and WELLS FARGO & COMPANY/MN.
This table shows 11 bond principal holders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.